It's interesting -- in the paper it says that the samples they used to assess the sensitivity (it was a different population for specificity) were from people w

It's interesting -- in the paper it says that the samples they used to assess the sensitivity (it was a different population for specificity) were from people who had (mostly) been elderly and hospitalized, and that they do not know how it would perform in subclinical or asymptomatic cases. I admit being super not-objective about my reading, since I had this test done last week and came back negative despite losing my sense of smell completely in late March - early April (I live in Boston and was exposed to people who tested positive). It will be interesting to see more data on the Abbott and Roche tests on the subclinical / asymptomatic population.